Variant Bio

United States
Seattle, Washington, United States, 98102

Company profile

Variant Bio company profile

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. Variant Bio was founded in 2018 and headquartered in Seattle, Washington.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
98102
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$129.7M
Last funding
Series B / $105M / 2021-11-09
Last equity funding
Series B / $105M
Investors
8
Lead investors
2
Founders
3
Articles
40

Founders and investors

Founders

Kaja WasikStephane Castel

Lead investors

Lux CapitalSoftBank Vision Fund

Investors

Alexandria Venture InvestmentsCasdin CapitalGeneral CatalystLux CapitalSoftBank Vision Fund